| Name | Title | Contact Details |
|---|
Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.
Developed by spine specialists, the SpineZone Method relieves long-term back and neck injuries without resorting to surgery.
Pascal Metrics is the preeminent provider in the healthcare industry of real-time patient safety and clinical improvement services to reduce patient harm and related cost.
EvidenceCare is the only decision support tool designed exclusively for clinicians that delivers evidence-based medicine individualized for each patient they treat. Our patent pending technology lowers costs and improves outcomes in a way that benefits patients, providers, payers, and clinics. We provide the evidence, so you can provide the care.
After coaching over 10,000 clients and students from 30 countries in the past 10 years, we are proud to be pioneering the new generation of health coaches who are changing the consciousness of the planet. Our curriculum is based on cutting-edge psychology, brain science, intuitive listening, habit change and healthy lifestyle design. Graduates of our school are some of the most successful Health Coaches in the world. Why? We believe health coaching is one of the most lucrative and fulfilling careers you can choose. We also believe that health coaching will change the consciousness of the planet. There are lots of decent coaches out there, but not that many truly masterful coaches. We want to change that. What you can expect from us is everything we`ve got to help you be successful, so that like our current students, 6 months from now you will look back on this moment as the best decision you ever made for your career and your own personal growth. Stacey Morgenstern and Carey Peters are the founders and primary teachers of Health Coach Institute, a world-class international coach training company in service of creating leaders in the art, science, and business of health coaching. With over 10,000 graduates from 30 countries, they are pioneering the new generation of aspiring health coaches who want to turn their holistic passion into a thriving, meaningful career that raises the consciousness of the planet.